Drug:
Reaction: ECZEMA
20260101 - 20261231
No. 1 - 100
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 1 | 26556146 |
US |
69 | |
Cataract operation, Visual impairment, Vitreous floaters, Eczema, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, HYALURONIC ACID, |
||||
| 2 | 26556470 |
US |
59 | 1 |
Eczema, |
||||
TRALOKINUMAB-LDRM, |
||||
| 3 | 26557166 |
US |
29 | 2 |
Eczema, Pruritus, |
||||
DUPILUMAB, |
||||
| 4 | 26557179 |
US |
22 | 1 |
Eczema, Dry skin, Skin exfoliation, Product dose omission issue, |
||||
DUPILUMAB, |
||||
| 5 | 26557243 |
US |
58 | 2 |
Eczema, Pruritus, Sleep disorder due to a general medical condition, Dry skin, Skin exfoliation, Injection site bruising, |
||||
DUPILUMAB, |
||||
| 6 | 26557318 |
US |
38 | 1 |
Eczema, Skin irritation, |
||||
DUPILUMAB, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, |
||||
| 7 | 26557319 |
US |
2 | |
Eczema, Inappropriate schedule of product administration, |
||||
DUPILUMAB, |
||||
| 8 | 26557391 |
US |
59 | 2 |
Adjustment disorder with anxiety, Eczema, Intentional dose omission, Psoriasis, Rash, Dermatitis psoriasiform, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, |
||||
| 9 | 26557433 |
US |
1 | |
Asthma, Hypersensitivity, Eczema, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 10 | 26557564 |
US |
2 | |
Pain, Eczema, Rash, |
||||
DUPILUMAB, |
||||
| 11 | 26557588 |
US |
62 | 1 |
Dermatitis atopic, Eczema, Skin exfoliation, Pruritus, Inappropriate schedule of product administration, |
||||
DUPILUMAB, |
||||
| 12 | 26557592 |
US |
35 | 2 |
Eczema, Skin fissures, Dyshidrotic eczema, Blister, Product dose omission issue, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 13 | 26558050 |
US |
41 | 2 |
Skin ulcer, Fatigue, Eczema, Pruritus, Skin fissures, Skin exfoliation, Dry skin, Sleep disorder due to a general medical condition, Skin haemorrhage, Skin weeping, |
||||
DUPILUMAB, BUPROPION, BUSPIRONE HYDROCHLORIDE, ACETAMINOPHEN, ASPIRIN AND CAFFEINE, ACETAMINOPHEN, ASPIRIN, CAFFEINE, TURMERIC, CURCUMA AROMATICA ROOT, INDIAN FRANKINCENSE, GINGER, FEVERFEW, IBUPROFEN, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, UBROGEPANT, |
||||
| 14 | 26558478 |
US |
70 | |
Product dose omission issue, Eczema, |
||||
LENIOLISIB, |
||||
| 15 | 26558848 |
US |
18 | |
Eczema herpeticum, Pain of skin, Skin burning sensation, Pruritus, Eczema, Rash, |
||||
NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, DUPILUMAB, UPADACITINIB, |
||||
| 16 | 26559058 |
US |
60 | 2 |
Retinal detachment, Eczema, Eczema eyelids, Eye pruritus, |
||||
UPADACITINIB, |
||||
| 17 | 26559083 |
GB |
53 | 1 |
Alcohol poisoning, Accidental overdose, Abdominal discomfort, Burns second degree, Cardiac murmur, Catarrh, Cerebrovascular accident, Confusional state, Drug ineffective, Depression, Dysgeusia, Fatigue, Eczema, Frequent bowel movements, Gingival pain, Haematochezia, Hypopnoea, Inappropriate schedule of product administration, Migraine, Headache, Nightmare, Off label use, Pain, Pain in extremity, Palpitations, Parosmia, Pulmonary embolism, Pyrexia, Rash, Rectal haemorrhage, Rhinitis, Somnolence, Steroid dependence, Stress, Swollen tongue, Systemic lupus erythematosus, Tinnitus, Tubulointerstitial nephritis, Vertigo, Weight decreased, Impaired quality of life, Loss of personal independence in daily activities, Impaired work ability, Medication error, Product use in unapproved indication, Intentional product use issue, |
||||
CANDESARTAN CILEXETIL, LATANOPROST, FESOTERODINE FUMARATE, BUDESONIDE, FELODIPINE, FELODIPINE EXTENDED-RELEASE TABLETS, ROSUVASTATIN, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, DAPAGLIFLOZIN, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, ROSUVASTATIN, HYDROCORTISONE ACETATE, HYDROCORTISONE, VEDOLIZUMAB, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, OXYCODONE, ERGOCALCIFEROL, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, LISDEXAMFETAMINE DIMESYLATE, LISDEXAMFETAMINE, LISDEXAMFETAMINE DIMESYLATE CAPSULES, WARFARIN SODIUM, WARFARIN, VEDOLIZUMAB, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, FUROSEMIDE, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ADALIMUMAB, INFLIXIMAB-DYYB, LISDEXAMFETAMINE DIMESYLATE, LISDEXAMFETAMINE, LISDEXAMFETAMINE DIMESYLATE CAPSULES, DESOXIMETASONE, ACETAMINOPHEN, DEXTROMETHORPHAN HBR, ACETAMINOPHEN AND DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN AND CAFFEINE, ACETAMINOPHEN AND PHENYLEPRINE HCL, ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, DEXTROMETHORPHAN HBR, PRAVASTATIN SODIUM, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, RAMIPRIL, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, ESOMEPRAZOLE MAGNESIUM, AMLODIPINE BESYLATE, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, DORZOLAMIDE HYDROCHLORIDE, DORZOLAMIDE, RIVAROXABAN, METHOTREXATE, METHOTREXATE SODIUM, TAMSULOSIN HYDROCHLORIDE, FOLIC ACID, TOFACITINIB, BISOPROLOL FUMARATE, EMPAGLIFLOZIN, LANSOPRAZOLE, NITROFURANTOIN, NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS), ALUMINUM HYDROXIDE AND MAGNESIUM CARBONATE, PREGABALIN, LATANOPROST, MINERAL OIL, NAPHAZOLINE HYDROCHLORIDE, TETRAHYDROZOLINE HYDROCHLORIDE, CAFFEINE, CALCIUM CHLORIDE INJECTION, CALCIUM CHLORIDE, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, CALCIUM CARBONATE, ANTACID, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, FELODIPINE, FELODIPINE EXTENDED-RELEASE TABLETS, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, DAPAGLIFLOZIN, LATANOPROST, BUDESONIDE, BUDESONIDE, BUDESONIDE, BUDESONIDE, BUDESONIDE, ROSUVASTATIN, ROSUVASTATIN, HYDROCORTISONE ACETATE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, ROSUVASTATIN, ROSUVASTATIN, ROSUVASTATIN, ROSUVASTATIN, ROSUVASTATIN, BUDESONIDE, BUDESONIDE, BUDESONIDE, BUDESONIDE, BUDESONIDE, BUDESONIDE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, DESOXIMETASONE, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, ADALIMUMAB, ADALIMUMAB, VEDOLIZUMAB, WARFARIN SODIUM, WARFARIN, OXYCODONE, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, ROSUVASTATIN, |
||||
| 18 | 26559545 |
US |
2 | |
T-cell lymphoma, Eczema, Rash pruritic, Rash, Injection site pain, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, CALCIUM, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, SIMVASTATIN, CETIRIZINE HYDROCHLORIDE, MINOXIDIL, |
||||
| 19 | 26559957 |
JP |
71 | 1 |
Gallbladder cancer, Oedema peripheral, Myocardial infarction, Pneumonia aspiration, Upper gastrointestinal haemorrhage, COVID-19 pneumonia, Eczema, |
||||
LEUPROLIDE ACETATE, LANSOPRAZOLE, BETAMETHASONE DIPROPIONATE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, OMEGA-3-ACID ETHYL ESTERS, LEVOCETIRIZINE DIHYDROCHLORIDE, |
||||
| 20 | 26560042 |
US |
2 | |
Rheumatoid arthritis, Vision blurred, Alopecia, Madarosis, Eczema, Peripheral swelling, Therapeutic response decreased, Herpes simplex, |
||||
DUPILUMAB, |
||||
| 21 | 26560114 |
US |
7 | 2 |
Lacrimation increased, Eczema, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 22 | 26560246 |
US |
37 | 1 |
Eczema, |
||||
DUPILUMAB, |
||||
| 23 | 26560267 |
US |
27 | 2 |
Eczema, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 24 | 26560272 |
US |
50 | 1 |
Eczema, Skin irritation, Pruritus, Rash, |
||||
DUPILUMAB, DUPILUMAB, UPADACITINIB, |
||||
| 25 | 26560285 |
US |
20 | 2 |
Eczema, |
||||
DUPILUMAB, |
||||
| 26 | 26560287 |
US |
55 | 1 |
Rash macular, Pruritus, Eczema, Skin burning sensation, |
||||
DUPILUMAB, |
||||
| 27 | 26560294 |
US |
50 | 1 |
Eczema, Pruritus, Rash, Skin discolouration, Product dose omission in error, Incorrect dose administered, |
||||
DUPILUMAB, |
||||
| 28 | 26560316 |
US |
8 | 2 |
Eczema, |
||||
DUPILUMAB, |
||||
| 29 | 26560348 |
US |
7 | 1 |
Eczema, Inappropriate schedule of product administration, |
||||
DUPILUMAB, |
||||
| 30 | 26560355 |
US |
45 | 2 |
Eczema, Injection site irritation, Injection site erythema, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 31 | 26560382 |
US |
79 | 2 |
Eczema, Product dose omission issue, Erythema, Pruritus, Skin irritation, |
||||
DUPILUMAB, |
||||
| 32 | 26560418 |
US |
29 | 1 |
Eczema, Pruritus, Product dose omission issue, Sleep disorder due to a general medical condition, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 33 | 26560428 |
US |
16 | 2 |
Eczema, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 34 | 26560480 |
US |
54 | 1 |
Eczema, Skin exfoliation, Pruritus, Product dose omission issue, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 35 | 26560647 |
EU |
1 | |
Hypotension, Gynaecomastia, Breast discharge, Dermatitis, Eczema, Hyperhidrosis, Visual acuity reduced, |
||||
SPARSENTAN, |
||||
| 36 | 26560740 |
EU |
36 | 2 |
Hypotension, Dizziness, Eczema, Acne, |
||||
SPARSENTAN, |
||||
| 37 | 26560775 |
CA |
4 | 1 |
Eczema, Oedema, Drug ineffective, Product use in unapproved indication, Off label use, |
||||
PROPRANOLOL HYDROCHLORIDE, PROPRANOLOL HYDROCHLORIDE, SPIRONOLACTONE, TRAMETINIB, |
||||
| 38 | 26561416 |
US |
65 | |
Rash, Skin mass, Skin weeping, Migraine, Pruritus, Rash papular, Scab, Erythema, Dermatitis, Drug eruption, Rash erythematous, Exfoliative rash, Skin discolouration, Eczema, Skin erosion, Hypersensitivity, |
||||
NEMOLIZUMAB-ILTO, HYDROCORTISONE, HYDROXYZINE, ATENOLOL, |
||||
| 39 | 26561465 |
US |
57 | |
Eczema, |
||||
NEMOLIZUMAB-ILTO, |
||||
| 40 | 26550003 |
43 | 2 | |
Drug ineffective, Product with quality issue administered, Product physical consistency issue, Eczema, |
||||
TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, |
||||
| 41 | 26550200 |
US |
19 | 2 |
Oral discomfort, Drug ineffective, Eczema, Pruritus, Skin fissures, Skin exfoliation, Dry skin, |
||||
DUPILUMAB, LEBRIKIZUMAB-LBKZ, |
||||
| 42 | 26551496 |
US |
87 | 1 |
Dizziness, Vertigo, Hypotension, Eczema, Intentional dose omission, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 43 | 26551813 |
US |
1 | |
Eczema, Headache, Epistaxis, |
||||
ENZALUTAMIDE, ENZALUTAMIDE, ENZALUTAMIDE, DEGARELIX, |
||||
| 44 | 26552216 |
US |
1 | |
Eczema, |
||||
TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, DUPILUMAB, FLECAINIDE ACETATE TABLET, FLECAINIDE ACETATE, IRBESARTAN, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, CETIRIZINE HYDROCHLORIDE, |
||||
| 45 | 26552788 |
US |
38 | 2 |
Rash pruritic, Eczema, |
||||
RISANKIZUMAB-RZAA, |
||||
| 46 | 26552956 |
US |
61 | 1 |
Cutaneous T-cell lymphoma, Dermatitis exfoliative generalised, Neurodermatitis, Skin exfoliation, Dermatitis, Pain in extremity, Gait disturbance, Dyspnoea exertional, Weight decreased, White blood cell count increased, Skin hyperplasia, Peripheral swelling, Limb discomfort, Oedema, Joint stiffness, Eczema, Rash pruritic, Skin discolouration, Skin hypertrophy, Drug ineffective, Arthralgia, |
||||
DUPILUMAB, ZOLPIDEM TARTRATE, AMLODIPINE, ALLOPURINOL, ALBUTEROL SULFATE, AMMONIUM LACTATE, CLOPIDOGREL, CLOPIDOGREL BISULFATE, CETIRIZINE HCL, CETIRIZINE, LOSARTAN, HYDROCHLOROTHIAZIDE, GABAPENTIN, KETOCONAZOLE, KETOCONAZOLE FOAM, KETOCONAZOLE CREAM, 2%, METHYLPREDNISOLONE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, HYDROCODONE BITARTRATE AND ACETAMINOPHEN, LORATADINE, LORATADINE ORAL, INDOMETHACIN, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, MONTELUKAST SODIUM, MONTELUKAST, HYDROXYZINE HYDROCHLORIDE, HYDROXYZINE, HYDROXYZINE HYDROCHLORIDE ORAL, BUMETANIDE, FUROSEMIDE, GABAPENTIN, MUPIROCIN, MUPIROCIN CALCIUM, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, RIVAROXABAN, PREDNISONE, |
||||
| 47 | 26553201 |
US |
28 | 2 |
Loss of personal independence in daily activities, Eczema, |
||||
TRALOKINUMAB-LDRM, TRALOKINUMAB-LDRM, |
||||
| 48 | 26553640 |
US |
1 | |
Malignant melanoma, Squamous cell carcinoma, Basal cell carcinoma, Actinic keratosis, Eczema asteatotic, Eczema, Pruritus, Sunburn, |
||||
APREMILAST, CEPHALEXIN, DOXYCYCLINE HYCLATE, DOXYCYCLINE, DOXYCLYCLINE HYCLATE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, IBUPROFEN SODIUM, IBUPROFEN, IBUPROFEN TABLETS, COATED, METOPROLOL TARTRATE, METOROPROLOL TARTRATE, METOPROLOL, DESONIDE, |
||||
| 49 | 26553973 |
EU |
64 | 1 |
Eczema, |
||||
DABRAFENIB, TRAMETINIB, |
||||
| 50 | 26569767 |
63 | 1 | |
Abdominal pain, Agitation, Eczema, Insomnia, Pruritus, Psoriasis, Rash, |
||||
GALCANEZUMAB-GNLM, |
||||
| 51 | 26549274 |
US |
57 | 1 |
Dermatitis atopic, Eczema, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, |
||||
| 52 | 26549297 |
US |
2 | |
Eczema, Disease recurrence, |
||||
DUPILUMAB, |
||||
| 53 | 26549300 |
US |
57 | 2 |
Eczema, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 54 | 26549320 |
US |
59 | 2 |
Eczema, Pruritus, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 55 | 26549325 |
US |
20 | 2 |
Eczema, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 56 | 26549355 |
US |
38 | 1 |
Eczema, Pruritus, Sleep disorder due to a general medical condition, Product dose omission issue, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, |
||||
| 57 | 26549356 |
US |
2 | |
Eczema, Injection site rash, Asthma, |
||||
DUPILUMAB, |
||||
| 58 | 26549377 |
US |
45 | 2 |
Eczema, Rash erythematous, Rash, Product dose omission in error, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 59 | 26549384 |
US |
36 | 2 |
Dermatitis, Product use in unapproved indication, Eczema, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 60 | 26549388 |
US |
1 | 1 |
Eczema, Intentional dose omission, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 61 | 26549396 |
US |
61 | 2 |
Scratch, Eczema, Product dose omission issue, Rash pruritic, Skin ulcer, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 62 | 26549405 |
US |
35 | 1 |
Eczema, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 63 | 26549413 |
US |
2 | |
Eczema, |
||||
DUPILUMAB, |
||||
| 64 | 26549438 |
US |
73 | 1 |
Eczema, Rash, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 65 | 26549446 |
US |
70 | 2 |
Rash erythematous, Pruritus, Skin burning sensation, Eczema, Product use in unapproved indication, |
||||
DUPILUMAB, |
||||
| 66 | 26549450 |
US |
14 | 2 |
Migraine, Eczema, |
||||
DUPILUMAB, |
||||
| 67 | 26549464 |
US |
69 | 2 |
Eczema, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 68 | 26549467 |
US |
38 | 2 |
Eczema, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 69 | 26549492 |
US |
15 | 1 |
Eczema, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 70 | 26549510 |
US |
36 | 1 |
Dry skin, Haemorrhage, Eczema, Scratch, Skin exfoliation, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 71 | 26549522 |
US |
73 | 1 |
Eczema, Pruritus, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 72 | 26549531 |
US |
1 | |
Injection site pain, Eczema, Pruritus, Intentional dose omission, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 73 | 26549535 |
US |
84 | 2 |
Eczema, Pruritus, |
||||
DUPILUMAB, NEMOLIZUMAB-ILTO, |
||||
| 74 | 26549548 |
US |
19 | 2 |
Eczema, Drug ineffective, |
||||
DUPILUMAB, |
||||
| 75 | 26549574 |
US |
29 | 2 |
Eczema, Erythema, Pruritus, Dry skin, Rash, Haemorrhage, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, |
||||
| 76 | 26549581 |
US |
63 | 2 |
Eczema, |
||||
DUPILUMAB, |
||||
| 77 | 26549585 |
US |
69 | 2 |
Eczema, Rash, Product dose omission issue, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 78 | 26549598 |
US |
2 | |
Eczema, Product dose omission issue, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, |
||||
| 79 | 26549607 |
US |
58 | 2 |
Eczema, Drug ineffective, |
||||
DUPILUMAB, |
||||
| 80 | 26549645 |
US |
21 | 1 |
Dry skin, Eczema, Pain, Skin exfoliation, |
||||
DUPILUMAB, |
||||
| 81 | 26549650 |
US |
1 | |
Eczema, Product dose omission issue, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 82 | 26549653 |
US |
43 | 1 |
Eczema, Dry skin, Skin exfoliation, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 83 | 26549662 |
US |
7 | 1 |
Insomnia, Eczema, Pruritus, Product dose omission in error, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, DUPILUMAB, |
||||
| 84 | 26549709 |
US |
12 | 2 |
Eczema, Pruritus, |
||||
DUPILUMAB, TRALOKINUMAB-LDRM, |
||||
| 85 | 26546752 |
US |
2 | |
Viral infection, Eczema, |
||||
DUPILUMAB, |
||||
| 86 | 26546841 |
US |
1 | 2 |
Injection site pain, Eczema, Rash erythematous, |
||||
DUPILUMAB, |
||||
| 87 | 26546974 |
US |
48 | 2 |
Eczema, Pruritus, Skin swelling, Product use in unapproved indication, |
||||
DUPILUMAB, |
||||
| 88 | 26546977 |
US |
18 | 1 |
Eczema, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 89 | 26547010 |
US |
2 | |
Eczema, Upper respiratory tract infection, Pruritus, |
||||
DUPILUMAB, CICLOPIROX, HYDROXYZINE HYDROCHLORIDE, HYDROXYZINE, HYDROXYZINE HYDROCHLORIDE ORAL, LOSARTAN POTASSIUM, LOSARTAN, MONTELUKAST, NIFEDIPINE, ROSUVASTATIN, |
||||
| 90 | 26547026 |
US |
56 | 2 |
Eczema, Off label use, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, |
||||
| 91 | 26547036 |
US |
85 | 2 |
Eczema, Blister, Pruritus, Chills, Rash, Swelling, |
||||
DUPILUMAB, |
||||
| 92 | 26547087 |
US |
2 | |
Eczema, |
||||
DUPILUMAB, |
||||
| 93 | 26547137 |
US |
2 | |
Eczema, Pruritus, Skin swelling, Product storage error, Product dose omission issue, |
||||
DUPILUMAB, |
||||
| 94 | 26547276 |
US |
54 | 1 |
Eczema, Therapeutic response decreased, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 95 | 26547345 |
US |
1 | |
Eczema, Therapeutic response shortened, |
||||
DUPILUMAB, DUPILUMAB, UPADACITINIB, |
||||
| 96 | 26547527 |
US |
40 | 2 |
Eczema, Pruritus, Dry skin, Skin exfoliation, |
||||
DUPILUMAB, |
||||
| 97 | 26547531 |
US |
68 | 2 |
Eczema, Product dose omission issue, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 98 | 26547641 |
US |
8 | 1 |
Injection site swelling, Eczema, Rash erythematous, Rash, Product dose omission in error, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 99 | 26547680 |
US |
59 | 2 |
Eczema, Product dose omission issue, |
||||
DUPILUMAB, |
||||
| 100 | 26547681 |
US |
5 | 1 |
Eczema, |
||||
DUPILUMAB, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-04-28